Conference abstract · 14 Jun 2021
Conference abstract
BA/BE Challenges to generic pharmaceutical industry
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Bioequivalence testing is playing a vital role in generic drug development. BA/BE studies are important elements in support of INDs, NDAs, ANDAs, and their supplements. To introduce a generic drug in to a regulated market Generic industry need to meet the stringent criteria in the same way as innovative drugs. One must have a clear picture on designing bioequivalence studies to face the cost challenges in BA/BE studies This presentation reviews the different methods to establish bioavailability and/or demonstrate bioequivalence for pharmaceutical products and specific methods to establish bioequivalence and validity of these methods for regulatory acceptance of the specific products. The presentation also focuses on bioequivalence determination for products related to various therapeutic areas (Locally acting GI products, Topical products, Respiratory products-Nasal Sprays/ Inhalations, Liposomal Injectables, Opthalmics and complex drug products like biosimilars) and their limitations and regulatory acceptance in the related areas. It also describes BA/BE challenges particularly in case of product failures related to solid orals(highly viable products & ER dosage forms) and products related to different therapeutic areas(criticality in designing and conducting PD endpoint studies and comparative clinical studies which involves high cost & time consuming with respect to patient recruitment) and uncertainty in case of a product failure
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 21 Oct 2013
Australian pharmaceutical patent system under review - To ‘balance’ the interests of pharmaceutical product innovators and the generics industry
Conference abstract
Challenges and opportunities: Entwined twins of generic pharmaceutical formulation development
Conference abstract · 17 Aug 2015
Drug delivery and generic medicine: The challenges ahead - choose where to play - MENA as an industry model
Article · 27 Nov 2024
The Pharmaceutical Industry: Innovation, Impact, and Challenges
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Article · 5 Oct 2026
Long COVID in pediatric and young adult patients: a review of evaluation for microvascular changes, endothelial dysfunction, and arterial stiffness
Article · 12 Jun 2026
Advances in Bioavailability Through Innovative Drug Delivery Systems and Formulation Technologies
Article · 12 Jun 2026
Bioequivalence Study Design and Methodological Approaches in Generic Drug Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “A.T. Bapuji”
